How to Create a Tax Efficient Exit Strategy for Founders

Two founders sell nearly identical companies in the same month. Same revenue, same buyer, same headline price. One wires home roughly 75% of the proceeds. The other keeps closer to 50%. The difference wasn't their lawyer's hourly rate or some exotic offshore trick. It was a handful of decisions made years earlier, when the exit still felt like a distant hypothetical.

That gap is what I want to talk about, because most founders I meet only start thinking about how to create a tax efficient exit strategy when a term sheet is already on the table. By then, the cheap moves are gone. The expensive ones are all that's left.

The map of your exit tax bill: where every dollar actually goes

Before you optimize anything, you need to see the pieces. A founder's exit tax rarely has one line. It has four or five, and each has its own rules.

The first bite is character of income. Is your gain taxed as long-term capital gains, or does part of it get pulled into ordinary-income rates? Sellers of a corporation often assume "capital gains," then discover that in an asset sale, goodwill, inventory, and depreciation recapture can each be taxed differently. That's the difference between a rate in the low double digits and one in the high thirties.

Second is entity type. A C-corp, an S-corp, and an LLC are not interchangeable when the buyer arrives. They change who gets taxed, on what, and twice in some cases.

Stock sale vs asset sale: the veto that reshapes your tax

Buyers almost always prefer an asset sale. They get a step-up in basis and can depreciate the assets. Sellers almost always prefer a stock sale, because the gain is cleaner capital gains. That tension is the deal.

Here's the practical consequence: if the buyer insists on an asset sale, your tax exposure can jump by 15 to 25 percentage points of the enterprise value, depending on what's inside the company. If your buyer insists on stock, you likely keep capital-gains treatment but may give up a little on price. Neither is free.

The move most founders miss: this negotiation happens in the letter of intent, months before closing. Once the deal structure is set, your tax planner has almost no room to maneuver.

Deal structure	Typical seller treatment	Who usually wants it	Main risk to you
Stock sale (C-corp)	Capital gains, potential QSBS exclusion	Seller	Buyer inherits liabilities, may demand a price cut
Asset sale	Mixed: recapture, ordinary income on some assets	Buyer	Effective rate can climb sharply
Installment sale	Gain spread across tax years	Either, when financing is involved	Imputed interest, buyer default risk
Pre-exit gifting to trust	Reduces seller's taxable estate	Seller (planned years ahead)	Must be done well before a valuation spike

QSBS (Section 1202): the lever most C-corp founders leave on the table

If you run a C-corp and you've held qualified stock for the required period, Section 1202 can exclude a large share of your gain from federal tax entirely. I want to be careful here, because the rules have real thresholds and conditions and I'm not your accountant — but the shape of the benefit is worth understanding even if you hire the best team in your state.

The mechanism: stock issued by a domestic C-corp, acquired at original issuance, held long enough, and used in an active business. Meet the conditions and your gain on a qualifying sale can be excluded up to a cap that's adjusted over time, with the exclusion percentage rising the longer you hold. For founders who set up correctly and waited, this is frequently the difference between a low single-digit federal rate and a rate north of 20% on the same sale.

Why so many founders accidentally disqualify themselves

Most disqualifications aren't dramatic. They're administrative.

• Converting from an LLC to a C-corp at the wrong moment, so the holding period restarts.
• Issuing stock to early contractors without the paperwork that proves original issuance.
• Letting the company drift into a business category the rules don't favor (certain service and financial lines get excluded).
• Missing the 83(b) election window on restricted stock, which changes the clock on everything downstream.

Notice a pattern? These are all things you get right in year one or year two, not in year seven. I have watched a founder lose six figures of clean exclusion benefit because a conversion happened at a moment that felt convenient rather than at a moment that preserved the clock.

State treatment differs too. Some states conform to the federal exclusion, some don't, and a few have their own version with different caps. Your effective rate depends on both layers.

The takeaway: if you're a C-corp founder even three years from a sale, verify your QSBS eligibility now. It's the highest-leverage, lowest-cost check on this entire page.

Spreading and deferring the gain without getting burned

An installment sale lets you spread the gain across multiple tax years, which can keep more of it in lower brackets and defer the rest. Sounds clean. It isn't always.

The catch is imputed interest: the tax authorities assume a minimum interest rate on deferred payments, and if your agreement charges less, they recharacterize part of the gain as interest income, taxed at ordinary rates. So the deferral benefit shrinks unless you price the note correctly.

Then there's counterparty risk. If your buyer is a private equity firm with a five-year hold and a levered balance sheet, you're a creditor. If they restructure, your deferred payments can get caught in the crossfire.

Multi-year sales and holding back equity

A cleaner variant many founders use: sell a majority stake now and retain a meaningful minority, then sell the rest in a later transaction. This can push a second gain into a different tax year and often a different law regime.

But does it actually work? It depends on the buyer's appetite and your tolerance for staying tied to a company you no longer control. I've seen it work beautifully for founders who sold 70% at close and 30% two years later. I've also watched a retained stake lose half its value when the acquirer's integration went sideways.

The takeaway: deferral is a tool, not a strategy. It trades tax certainty today for counterparty and law-change risk tomorrow. Decide if that trade suits you before the buyer sets the terms.

Where you live at closing can outweigh everything else

This is the section most founders skim and later regret. State and local taxes on a large exit can add 5 to 13 percentage points to your effective rate, and a handful of states tax capital gains as ordinary income with no preferential treatment at all.

Relocating before a sale is legal and common, but it isn't a magic wand. States have residency and domicile rules, and they look at where you actually live, where your ties are, and how long you've been there. A change of address two months before closing, with the house, the family, and the driver's license still in the old state, is the kind of thing that gets unwound.

Doing it properly means the move happens years ahead, with genuine ties to the new location, and it survives scrutiny. Founders who did this well usually began two to three years before any sale was real. Founders who tried to squeeze it into a quarter mostly didn't get the benefit they expected.

The takeaway: residency planning is a long game. Start the clock long before the buyer arrives, or don't bother.

Estate planning and philanthropy: gifting before the spike

If your company's value is about to climb, the cheapest tax move available to you is often to transfer ownership before that climb. Gifting shares to a trust, or to family, when the valuation is low means any future appreciation happens outside your estate.

The sequencing matters more than the vehicle. Gifting after a term sheet exists is worth a fraction of gifting two years earlier, because the valuation is already baked in. This is why the founders with the cleanest exits tend to have started conversations with a trusts and estates attorney in year four, not month four before closing.

Philanthropic structures follow the same logic. Donating appreciated pre-exit stock to a donor-advised fund or a charitable remainder trust can avoid capital gains on that portion entirely, and it does so most effectively when the stock is donated before the sale, not after.

The cost of waiting until the LOI

By the time a letter of intent is signed, your options collapse. You can negotiate price. You can negotiate structure. You cannot retroactively fix a stock-issuance history, restart a QSBS holding period, or move three years of residence into one quarter.

The takeaway: the most valuable hour you spend on exit tax planning happens years before the exit. Everything after is damage control.

Putting it together: a rough order of operations

No single move wins this. It's a stack, and the order you stack them changes the result.

1. Years out: confirm entity type and stock-issuance history support QSBS if you're a C-corp.
2. Two to three years out: handle residency if relocation genuinely makes sense for you.
3. Two years out: start the gifting and trust conversations while valuation is still modest.
4. At LOI: fight the stock-vs-asset battle, because it's your last real chance.
5. At close: structure any deferred payments correctly to avoid imputed-interest penalties.

Look, the honest truth is that the founder who keeps 75% and the one who keeps 50% did not differ in intelligence. They differed in when they started paying attention. The tax code rewards the patient and punishes the hurried, and an exit is the one moment you can't rewind.

So the question worth sitting with isn't "what's my rate." It's this: if a buyer called tomorrow, how many of these decisions are already locked in? The answer tells you exactly how much room you still have — and how much you've quietly spent without noticing.